HomeNewsIndiaAuto sales may dip by up to 25% in FY21, sharpest decline in two decades: Ind-Ra

Auto sales may dip by up to 25% in FY21, sharpest decline in two decades: Ind-Ra

The decline (excluding in tractors) would be the steepest in the last two decades, much higher than that recorded during the global recession in 2008-09, and is likely to push industry volumes to the 2011-12 levels, Ind-Ra said in a statement.

June 09, 2020 / 18:27 IST
Story continues below Advertisement
When looking at the overall four-wheeler segment in India, hatchbacks and SUVs have been the ones doing well. While hatchbacks are favoured for the prices, SUVs are the big car of choice for many people. Sedans, on the other hand, haven’t been enjoying as much favour. Here’s a list of the best-selling sedans in the month of September.
When looking at the overall four-wheeler segment in India, hatchbacks and SUVs have been the ones doing well. While hatchbacks are favoured for the prices, SUVs are the big car of choice for many people. Sedans, on the other hand, haven’t been enjoying as much favour. Here’s a list of the best-selling sedans in the month of September.

The automobile sales may decline by up to 25 percent in this financial year as compared to 2019-20 due to a complete washout in April and minuscule sales last month, according to rating agency Ind-Ra.

The decline (excluding in tractors) would be the steepest in the last two decades, much higher than that recorded during the global recession in 2008-09, and is likely to push industry volumes to the 2011-12 levels, Ind-Ra said in a statement.

Story continues below Advertisement

The two-wheeler segment is expected to rebound faster, followed by passenger vehicles (PVs), while the decline in medium and heavy commercial vehicles (MHCV) is likely to be the steepest during 2020-21, it added.

The rating agency expects two-wheeler sales to decline by 20-22 percent, PV by 22-26 percent, light commercial vehicle (LCV) by 26-30 percent and MHCV by 35-45 percent YoY in 2020-21.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show